CMMB (Chemomab Therapeutics) Institutional Ownership: 4.88% (As of Jul. 07, 2026)


CMMB Chemomab Therapeutics Ltd CMMB
34 GF Score
Price $2.77
View Full Analysis

What is Chemomab Therapeutics Institutional Ownership?

Chemomab Therapeutics CMMB +14.94% 34 Institutional Ownership is 4.88% as of Jul. 07, 2026. GuruFocus rates CMMB with a GF Score™ of 34/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Chemomab Therapeutics's institutional ownership is 4.88%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Chemomab Therapeutics's Insider Ownership is 0.01%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Chemomab Therapeutics's Float Percentage Of Total Shares Outstanding is 97.35%.

Chemomab Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Chemomab Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemomab Therapeutics Institutional Ownership Chart

Chemomab Therapeutics Historical Data

The historical data trend for Chemomab Therapeutics can be seen below:

2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31
Institutional Ownership 4.86 4.86 4.43 4.42 4.42 0.03 0.03 0.03 0.02 0.02
CMMB
34GF Score
Chemomab Therapeutics Ltd CMMB
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemomab Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 4.88% mean?
Chemomab Therapeutics (CMMB) has a Institutional Ownership of 4.88% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chemomab Therapeutics and its competitors.
Is Chemomab Therapeutics' Institutional Ownership too high?
Chemomab Therapeutics' current Institutional Ownership is 4.88%. Overall, Chemomab Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Chemomab Therapeutics' Institutional Ownership compare to OSRH and TOVX?
Chemomab Therapeutics' Institutional Ownership of 4.88% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Chemomab Therapeutics and its competitors. Chemomab Therapeutics's current Institutional Ownership is 4.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemomab Therapeutics stock overvalued right now?
Chemomab Therapeutics (CMMB) has a current Institutional Ownership of 4.88%. The current Institutional Ownership is 4.88%. Chemomab Therapeutics' overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Chemomab Therapeutics (CMMB), the current Institutional Ownership is 4.88% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chemomab Therapeutics Business Description

Address 10 Habarzel Street, 10th Floor, Building C, Tel Aviv, ISR, 6158101
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
34GF Score

Get the complete analysis for CMMB

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price